ZA201800296B - A percutaneous absorption composition - Google Patents
A percutaneous absorption compositionInfo
- Publication number
- ZA201800296B ZA201800296B ZA2018/00296A ZA201800296A ZA201800296B ZA 201800296 B ZA201800296 B ZA 201800296B ZA 2018/00296 A ZA2018/00296 A ZA 2018/00296A ZA 201800296 A ZA201800296 A ZA 201800296A ZA 201800296 B ZA201800296 B ZA 201800296B
- Authority
- ZA
- South Africa
- Prior art keywords
- percutaneous absorption
- absorption composition
- composition
- percutaneous
- absorption
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2015/074553 WO2017037813A1 (ja) | 2015-08-29 | 2015-08-29 | 塩基性薬物とソルビン酸とを含有する経皮吸収組成物 |
| PCT/JP2016/075203 WO2017038767A1 (ja) | 2015-08-29 | 2016-08-29 | 経皮吸収組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201800296B true ZA201800296B (en) | 2019-04-24 |
Family
ID=58187853
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2018/00296A ZA201800296B (en) | 2015-08-29 | 2018-01-16 | A percutaneous absorption composition |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US9974858B2 (enExample) |
| EP (1) | EP3342423B1 (enExample) |
| JP (2) | JP6259117B2 (enExample) |
| KR (1) | KR20180039622A (enExample) |
| CN (1) | CN107427509B (enExample) |
| BR (1) | BR112018001387B8 (enExample) |
| CO (1) | CO2018001831A2 (enExample) |
| ES (1) | ES2864017T3 (enExample) |
| MX (1) | MX388148B (enExample) |
| MY (1) | MY189987A (enExample) |
| PH (1) | PH12018500271A1 (enExample) |
| RU (1) | RU2702356C2 (enExample) |
| SG (1) | SG11201800043UA (enExample) |
| UA (1) | UA123212C2 (enExample) |
| WO (2) | WO2017037813A1 (enExample) |
| ZA (1) | ZA201800296B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017037813A1 (ja) | 2015-08-29 | 2017-03-09 | 株式会社メドレックス | 塩基性薬物とソルビン酸とを含有する経皮吸収組成物 |
| US11559519B2 (en) | 2018-01-31 | 2023-01-24 | Medrx, Co., Ltd. | Tizanidine therapy system |
| US11186585B2 (en) | 2018-08-17 | 2021-11-30 | Kappa-Pharma LLC | Compositions and methods of enhancing opioid receptor engagement by opioid hexadienoates and optionally substituted hexadienoates |
| TWI772807B (zh) * | 2019-05-27 | 2022-08-01 | 日商救急藥品工業股份有限公司 | 外用製劑 |
| EP4010078A4 (en) * | 2019-08-11 | 2023-08-09 | Kappa-Pharma LLC | COMPOSITIONS AND METHODS FOR ENHANCING OPIOID RECEPTOR MOBILIZATION BY OPIOID HEXADENOATES AND OPTIONALLY SUBSTITUTED HEXADIENATES |
| US12103639B2 (en) * | 2021-06-03 | 2024-10-01 | Sram, Llc | Bicycle control system |
| JP2024532418A (ja) * | 2021-08-30 | 2024-09-05 | エルテーエス ローマン テラピー－ジステーメ アーゲー | グアンファシン及びモノカルボン酸を含むグアンファシンの経皮投与のための経皮治療システム |
| US20240398765A1 (en) * | 2021-10-15 | 2024-12-05 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system for the transdermal administration of tizanidine |
| CN116370439A (zh) * | 2022-04-01 | 2023-07-04 | 江苏山信药业有限公司 | 一种伐尼克兰透皮贴剂及其制备方法和其应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61172830A (ja) * | 1985-01-26 | 1986-08-04 | Showa Denko Kk | 皮膚外用剤組成物 |
| EP1201232B1 (en) * | 1999-07-27 | 2007-04-18 | Hisamitsu Pharmaceutical Co. Inc. | Patches for external use |
| US20040142024A1 (en) * | 1999-07-27 | 2004-07-22 | Hisamitsu Pharmaceutical Co., Inc. | Patch formulation for external use |
| NZ549939A (en) * | 2004-03-19 | 2009-12-24 | Mcneil Ab | Means for transdermal administration of nicotine |
| JP4807974B2 (ja) * | 2005-06-30 | 2011-11-02 | 帝國製薬株式会社 | 経皮吸収促進組成物 |
| CN101032474B (zh) * | 2006-03-06 | 2011-02-16 | 重庆医药工业研究院有限责任公司 | 一种治疗或预防神经系统疾病的雷沙吉兰透皮贴片及其制备方法 |
| CN101143127A (zh) * | 2007-10-25 | 2008-03-19 | 复旦大学 | 一种酚妥拉明外用制剂及其制备方法 |
| WO2009066457A1 (ja) * | 2007-11-22 | 2009-05-28 | Medrx Co., Ltd. | 脂肪酸系イオン液体を有効成分とする外用剤組成物 |
| JP5537412B2 (ja) | 2008-02-27 | 2014-07-02 | 久光製薬株式会社 | 貼付製剤 |
| EP2311498A4 (en) | 2008-08-05 | 2013-07-24 | Medrx Co Ltd | EXTERNAL PREPARATION COMPRISING A FATTY ACID SALT OR A BENZOIC ACID SALT OF A PHARMACOLOGICALLY ACTIVE BASIC COMPONENT, AND PROCESS FOR PRODUCTION THEREOF |
| JP2012158521A (ja) * | 2009-04-17 | 2012-08-23 | Kureha Corp | 外用剤 |
| ES2574032T3 (es) * | 2009-09-07 | 2016-06-14 | Nipro Patch Co., Ltd. | Preparación absorbible por vía transdérmica |
| MX2012012318A (es) * | 2010-06-18 | 2012-11-21 | Merz Pharma Gmbh & Co Kgaa | Formulaciones en gel para el uso topico de derivados de 1-amino-alquiciclohexano. |
| DK2865376T4 (da) * | 2012-06-20 | 2022-07-18 | Medrx Co Ltd | Klæbende præparatsammensætning opnået ved hjælp af blanding af lægemiddel, organisk opløsningsmiddel, lipofil salvebasis og pulver |
| JP2014125483A (ja) | 2012-12-27 | 2014-07-07 | Lion Corp | 貼付剤 |
| WO2017037813A1 (ja) * | 2015-08-29 | 2017-03-09 | 株式会社メドレックス | 塩基性薬物とソルビン酸とを含有する経皮吸収組成物 |
-
2015
- 2015-08-29 WO PCT/JP2015/074553 patent/WO2017037813A1/ja not_active Ceased
- 2015-08-29 CN CN201580078659.1A patent/CN107427509B/zh active Active
-
2016
- 2016-08-29 RU RU2018110617A patent/RU2702356C2/ru active
- 2016-08-29 ES ES16841799T patent/ES2864017T3/es active Active
- 2016-08-29 JP JP2016558808A patent/JP6259117B2/ja active Active
- 2016-08-29 WO PCT/JP2016/075203 patent/WO2017038767A1/ja not_active Ceased
- 2016-08-29 SG SG11201800043UA patent/SG11201800043UA/en unknown
- 2016-08-29 MY MYPI2018700724A patent/MY189987A/en unknown
- 2016-08-29 BR BR112018001387A patent/BR112018001387B8/pt active IP Right Grant
- 2016-08-29 EP EP16841799.6A patent/EP3342423B1/en active Active
- 2016-08-29 MX MX2018002015A patent/MX388148B/es unknown
- 2016-08-29 KR KR1020187001366A patent/KR20180039622A/ko not_active Withdrawn
- 2016-08-29 UA UAA201803201A patent/UA123212C2/uk unknown
- 2016-09-28 US US15/279,210 patent/US9974858B2/en active Active
-
2017
- 2017-06-08 JP JP2017113200A patent/JP2017149782A/ja active Pending
-
2018
- 2018-01-16 ZA ZA2018/00296A patent/ZA201800296B/en unknown
- 2018-02-06 PH PH12018500271A patent/PH12018500271A1/en unknown
- 2018-02-22 CO CONC2018/0001831A patent/CO2018001831A2/es unknown
- 2018-04-23 US US15/960,392 patent/US10588973B2/en active Active
-
2020
- 2020-02-05 US US16/782,988 patent/US11382978B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PH12018500271A1 (en) | 2018-08-13 |
| US20200171156A1 (en) | 2020-06-04 |
| MY189987A (en) | 2022-03-22 |
| RU2018110617A (ru) | 2019-09-30 |
| ES2864017T3 (es) | 2021-10-13 |
| US11382978B2 (en) | 2022-07-12 |
| BR112018001387B8 (pt) | 2024-03-05 |
| EP3342423A1 (en) | 2018-07-04 |
| US20170056502A1 (en) | 2017-03-02 |
| JPWO2017038767A1 (ja) | 2017-09-07 |
| CO2018001831A2 (es) | 2018-05-21 |
| JP2017149782A (ja) | 2017-08-31 |
| CN107427509B (zh) | 2021-06-15 |
| EP3342423B1 (en) | 2021-03-10 |
| US10588973B2 (en) | 2020-03-17 |
| MX388148B (es) | 2025-03-19 |
| US20180236082A1 (en) | 2018-08-23 |
| JP6259117B2 (ja) | 2018-01-10 |
| CN107427509A (zh) | 2017-12-01 |
| RU2702356C2 (ru) | 2019-10-08 |
| EP3342423A4 (en) | 2018-07-25 |
| SG11201800043UA (en) | 2018-02-27 |
| MX2018002015A (es) | 2018-06-19 |
| BR112018001387A2 (pt) | 2018-09-11 |
| US9974858B2 (en) | 2018-05-22 |
| WO2017038767A1 (ja) | 2017-03-09 |
| BR112018001387B1 (pt) | 2023-09-05 |
| RU2018110617A3 (enExample) | 2019-09-30 |
| UA123212C2 (uk) | 2021-03-03 |
| WO2017037813A1 (ja) | 2017-03-09 |
| KR20180039622A (ko) | 2018-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201512030D0 (en) | Composition | |
| GB201506827D0 (en) | Composition | |
| SG11201800043UA (en) | A percutaneous absorption composition | |
| GB201505527D0 (en) | Composition | |
| GB201517273D0 (en) | Resist composition | |
| IL255108A0 (en) | Essay | |
| GB201506825D0 (en) | Composition | |
| GB201506830D0 (en) | Composition | |
| GB201506829D0 (en) | Composition | |
| GB201515640D0 (en) | Composition | |
| GB201504665D0 (en) | Composition | |
| PL3331498T3 (pl) | Kompozycja donosowa | |
| GB201517546D0 (en) | Composition | |
| IL252977A0 (en) | preparation | |
| GB201515639D0 (en) | Composition | |
| GB201504307D0 (en) | Composition | |
| GB201601838D0 (en) | A composition | |
| GB201514585D0 (en) | Composition | |
| GB201506828D0 (en) | Composition | |
| GB201505520D0 (en) | Composition | |
| PL3250203T3 (pl) | Kompozycja do przewlekłego stosowania jako środek wspomagający przybieranie na wadze | |
| GB201511697D0 (en) | Composition | |
| GB201509044D0 (en) | Composition | |
| GB201508722D0 (en) | Composition | |
| GB201506826D0 (en) | Composition |